Sanofi SNY
NASDAQ SNY
$48.39 +0.02 (+0.04%)
At close: Nov 16, 2026 · 4:00 PM EST

Sanofi (SNY) Long-Term Debt Repayments (2013 - 2014)

Updated

Sanofi (SNY) recorded Long-Term Debt Repayments of $2.96 billion in FY2025, up 307.9% from $726.25 million in FY2024.

Analysis

Sanofi (SNY) Long-Term Debt Repayments (2013 - 2014) Analysis & Trends

Starting with FY2009, Sanofi's Long-Term Debt Repayments history includes 17 years.

  • Annual Long-Term Debt Repayments has a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
  • Annual Long-Term Debt Repayments has ranged from $726.25 million in FY2024 to $3.98 billion in FY2023 over the past five years.
  • Per Business Quant data, SNY's Long-Term Debt Repayments was $726.25 million in FY2024 (-81.8%), $3.98 billion in FY2023 (+39.1%), $2.86 billion in FY2022 (+8.0%) and $2.65 billion in FY2021 (-41.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 1.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -4.91 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Sanofi 59.05 Bn 29.25 Bn 33.35 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -3.79 Bn
Dec 31, 2013 -3.84 Bn
API Access

Sanofi Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SNY&period=max&api_key=YOUR_API_KEY